Áron Roxin

725 total citations
18 papers, 598 citations indexed

About

Áron Roxin is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Áron Roxin has authored 18 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Áron Roxin's work include Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Nanoplatforms for cancer theranostics (4 papers). Áron Roxin is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Nanoplatforms for cancer theranostics (4 papers). Áron Roxin collaborates with scholars based in Canada and United States. Áron Roxin's co-authors include Gang Zheng, Kenneth K. Ng, Brian C. Wilson, François Bénard, Kuo‐Shyan Lin, Zhengxing Zhang, Chengcheng Zhang, Mojdeh Shakiba, Robert Weersink and Elizabeth Huynh and has published in prestigious journals such as ACS Nano, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Áron Roxin

18 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Áron Roxin Canada 14 197 172 154 128 122 18 598
Anil P. Bidkar India 16 195 1.0× 130 0.8× 103 0.7× 129 1.0× 71 0.6× 31 549
Alok Dube India 18 259 1.3× 274 1.6× 140 0.9× 170 1.3× 338 2.8× 50 759
Larisa Kuznetsova United States 5 372 1.9× 202 1.2× 86 0.6× 120 0.9× 51 0.4× 5 750
Nataliia Beztsinna Netherlands 17 280 1.4× 290 1.7× 48 0.3× 202 1.6× 69 0.6× 30 801
Matteo Ardini Italy 16 314 1.6× 135 0.8× 95 0.6× 126 1.0× 18 0.1× 34 656
Gabriella Csı́k Hungary 17 320 1.6× 218 1.3× 36 0.2× 283 2.2× 283 2.3× 48 768
Elisabetta Galbiati Italy 17 336 1.7× 153 0.9× 52 0.3× 194 1.5× 27 0.2× 43 801
Markus Lamla Germany 10 274 1.4× 107 0.6× 70 0.5× 91 0.7× 35 0.3× 23 512
Andrea Caporale Italy 19 656 3.3× 85 0.5× 116 0.8× 63 0.5× 41 0.3× 65 1.0k
Ran Xie China 15 774 3.9× 332 1.9× 203 1.3× 179 1.4× 77 0.6× 46 1.2k

Countries citing papers authored by Áron Roxin

Since Specialization
Citations

This map shows the geographic impact of Áron Roxin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Áron Roxin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Áron Roxin more than expected).

Fields of papers citing papers by Áron Roxin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Áron Roxin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Áron Roxin. The network helps show where Áron Roxin may publish in the future.

Co-authorship network of co-authors of Áron Roxin

This figure shows the co-authorship network connecting the top 25 collaborators of Áron Roxin. A scholar is included among the top collaborators of Áron Roxin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Áron Roxin. Áron Roxin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kuo, Hsiou‐Ting, Kuo‐Shyan Lin, Zhengxing Zhang, et al.. (2022). What a difference a methylene makes: replacing Glu with Asp or Aad in the Lys-urea-Glu pharmacophore of PSMA-targeting radioligands to reduce kidney and salivary gland uptake. Theranostics. 12(14). 6179–6188. 21 indexed citations
2.
Wang, Lei, Zhengxing Zhang, Helen Merkens, et al.. (2022). 68Ga-Labeled [Leu13ψThz14]Bombesin(7–14) Derivatives: Promising GRPR-Targeting PET Tracers with Low Pancreas Uptake. Molecules. 27(12). 3777–3777. 12 indexed citations
3.
Kwon, Daniel, Jerome Lozada, Zhengxing Zhang, et al.. (2020). High-Contrast CXCR4-Targeted 18F-PET Imaging Using a Potent and Selective Antagonist. Molecular Pharmaceutics. 18(1). 187–197. 25 indexed citations
4.
Zhang, Zhengxing, Hsiou‐Ting Kuo, Julie Rousseau, et al.. (2020). Evaluation of Met-Val-Lys as a Renal Brush Border Enzyme-Cleavable Linker to Reduce Kidney Uptake of 68Ga-Labeled DOTA-Conjugated Peptides and Peptidomimetics. Molecules. 25(17). 3854–3854. 21 indexed citations
5.
Lepage, Mathieu L., Áron Roxin, Zhengxing Zhang, et al.. (2019). Toward 18F‐Labeled Theranostics: A Single Agent that Can Be Labeled with 18F, 64Cu, or 177Lu. ChemBioChem. 21(7). 943–947. 24 indexed citations
6.
Kuo, Hsiou‐Ting, Mathieu L. Lepage, Kuo‐Shyan Lin, et al.. (2019). One-Step18F-Labeling and Preclinical Evaluation of Prostate-Specific Membrane Antigen Trifluoroborate Probes for Cancer Imaging. Journal of Nuclear Medicine. 60(8). 1160–1166. 20 indexed citations
7.
Roxin, Áron, Chengcheng Zhang, Mathieu L. Lepage, et al.. (2019). A Metal-Free DOTA-Conjugated 18F-Labeled Radiotracer: [18F]DOTA-AMBF3-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance. Bioconjugate Chemistry. 30(4). 1210–1219. 28 indexed citations
8.
Roxin, Áron, Chengcheng Zhang, Mathieu L. Lepage, et al.. (2018). Preliminary evaluation of 18F-labeled LLP2A-trifluoroborate conjugates as VLA-4 (α4β1 integrin) specific radiotracers for PET imaging of melanoma. Nuclear Medicine and Biology. 61. 11–20. 15 indexed citations
9.
Li, Ying, et al.. (2016). Facile synthesis and 18F-radiolabeling of α4β1-specific LLP2A-aryltrifluoroborate peptidomimetic conjugates. Bioorganic & Medicinal Chemistry Letters. 26(20). 5126–5131. 12 indexed citations
10.
Farhadi, Arash, Áron Roxin, Brian C. Wilson, & Gang Zheng. (2015). Nano-Enabled SERS Reporting Photosensitizers. Theranostics. 5(5). 469–476. 31 indexed citations
11.
Ng, Kenneth K., Mojdeh Shakiba, Elizabeth Huynh, et al.. (2014). Stimuli-Responsive Photoacoustic Nanoswitch for in Vivo Sensing Applications. ACS Nano. 8(8). 8363–8373. 103 indexed citations
12.
Marshall, Katie E., Raymond Thomas, Áron Roxin, et al.. (2014). Seasonal accumulation of acetylated triacylglycerols by a freeze-tolerant insect. Journal of Experimental Biology. 217(9). 1580–1587. 30 indexed citations
13.
Roxin, Áron, Juan Chen, Andrew S. Paton, Timothy P. Bender, & Gang Zheng. (2013). Modulation of Reactive Oxygen Species Photogeneration of Bacteriopheophorbide a Derivatives by Exocyclic E-Ring Opening and Charge Modifications. Journal of Medicinal Chemistry. 57(1). 223–237. 14 indexed citations
14.
Roxin, Áron, Thomas D. MacDonald, & Gang Zheng. (2013). Synthesis and characterization of a new natural product analog, 132-173-bacteriochlorophyllone a. Journal of Porphyrins and Phthalocyanines. 18(3). 188–199. 2 indexed citations
15.
Roxin, Áron, Juan Chen, Conor C. G. Scully, et al.. (2012). Conformational Modulation of in Vitro Activity of Cyclic RGD Peptides via Aziridine Aldehyde-Driven Macrocyclization Chemistry. Bioconjugate Chemistry. 23(7). 1387–1395. 32 indexed citations
16.
Roxin, Áron & Gang Zheng. (2012). Flexible Or Fixed: A Comparative Review Of Linear And Cyclic Cancer-Targeting Peptides. Future Medicinal Chemistry. 4(12). 1601–1618. 124 indexed citations
17.
Roxin, Áron, et al.. (2011). Photodecaging from 9-substituted 2,7-dihydroxy and dimethoxyfluorenes: competition between heterolytic and homolytic pathways. Photochemical & Photobiological Sciences. 10(6). 920–930. 6 indexed citations
18.
Lovell, Jonathan F., et al.. (2011). Porphyrin-Cross-Linked Hydrogel for Fluorescence-Guided Monitoring and Surgical Resection. Biomacromolecules. 12(9). 3115–3118. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026